BioLife Sciences Inc.
BLFE - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.49K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $5,489.00 |
|---|---|
| Enterprise Value | $5,872.00 |
| Earnings per Share | $-0.02 |
| Beta | -2290.12 |
| Outstanding Shares | 54,890,000 |
Return
| Return on Equity | 319716.51% |
|---|---|
| Return on Assets | -33508.75% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.02 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | -3.65 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About BioLife Sciences Inc.
3 employees
CEO: Justin De Four
BioLife Sciences Corp. specializes in the creation, licensing, and distribution of both antibacterial solutions and advanced non-contact human temperature screening technologies. Its diverse product portfolio includes sanitizing wipes, u...